Senior Director, Clinical Pharmacology
Rhythm Pharmaceuticals
Summary
Rhythm Pharmaceuticals is seeking a Senior Director, Clinical Pharmacology with demonstrable experience and expertise in early and late-phase clinical development of small molecule and peptide mono- and combination-therapy strategies to join our development team. The successful candidate will report to the CMO and play a critical leadership role in shaping and executing the clinical pharmacology strategy for programs targeting rare neuroendocrine diseases.
Job description
Responsibilities and Duties
- Lead and define the clinical pharmacology strategy for early and late-phase development programs, including mono- and combination-therapy approaches.
- Support and interface with DMPK workstreams to inform nonclinical study designs, translational PK/PD predictions, and interpretation.
- Design, execute, and interpret clinical pharmacology studies across the development lifecycle, including Ph 1: first-in-human, SAD/MAD, and drug-drug interaction studies, food effect; Ph 2: PK/PD and dose selection and optimization strategy; Ph 3 and beyond: Exposure response analyses supporting Ph 3 and registration, pediatric extrapolation, and dosing justification.
- Develop and oversee model-informed drug development (MIDD) strategies to optimize dose selection and regimen design.
- Collaborate closely with internal stakeholders across clinical operations, regulatory, biostatistics, and non-clinical functions to ensure alignment of pharmacology plans with overall development objectives.
- Author and review clinical pharmacology components of global regulatory documents (e.g., INDs, CTAs, IBs, briefing packages, NDAs/MAAs) and represent clinical pharmacology in regulatory agency interactions (FDA, EMA, PMDA etc.).
- Lead clinical pharmacology strategy supporting global registration, label optimization, lifecycle management activities, and post-marketing regulatory commitments.
- Provide scientific leadership in evaluating pharmacokinetic and pharmacodynamic data to inform clinical decision-making.
- Represent Rhythm at scientific congresses, advisory boards, investigator meetings, and interactions with external experts and key opinion leaders.
- Serve as a strategic advisor to the CMO and Clinical Leadership Team on clinical pharmacology, translational medicine, dose optimization, regulatory strategy, and portfolio decision making.
- Direct and oversee specialty CROs, external pharmacometrics consultants, and bioanalytical vendors to ensure high quality and compliance.
- Help establish functional infrastructure, external partnerships, standard operating procedures, and best practices to support the continued growth and evolution of clinical pharmacology capabilities at Rhythm.
Qualifications and Skills
- Ph.D., Pharm.D., or equivalent doctoral degree in Clinical Pharmacology, Pharmacokinetics, Pharmaceutical Sciences, or a related discipline.
- 12+ years of industry experience in clinical pharmacology, with a strong track record in early-phase and clinical development.
- Experience with rare disease and/or orphan drug development programs, combination therapy development, obesity, metabolic, endocrinology, or neuroendocrine therapeutic areas, and pediatric development and extrapolation strategies preferred.
- In-depth knowledge of regulatory requirements, ICH guidelines, and global health authority expectations for clinical pharmacology including formal meeting preparation and dossier authorship.
- Demonstrated experience supporting global regulatory submissions and participating in formal health authority interactions (FDA, EMA, PMDA, and/or other regulatory agencies).
- Proven ability to lead cross-functional teams and represent the function in strategic discussions and regulatory meetings.
- Familiarity with population PK/PD modeling and simulation tools desirable (e.g. NONMEM, Phoenix WinNonlin, R, Simcyp).
- Experience partnering with nonclinical DMPK/ADME functions and applying translational principles to support clinical development strategy preferred.
- Experience in obesity/metabolic/neuroendocrine therapeutic areas preferred.
- Proven ability to learn new information rapidly and effectively while working in a highly dynamic and fast-paced environment.
- Strong leadership, communication, and cross-functional collaboration skills.
- Excellent verbal and written communication with the ability to influence across the organization.
- Creative, innovative, strategic, problem-solving approach.
- Independent self-starter, but with an ability to be a strong team player in a highly collaborative environment.
Requirements
- Ph.D., Pharm.D., or equivalent doctoral degree in Clinical Pharmacology, Pharmacokinetics, Pharmaceutical Sciences, or a related discipline.
- 12+ years of industry experience in clinical pharmacology, with a strong track record in early-phase and clinical development.
- In-depth knowledge of regulatory requirements, ICH guidelines, and global health authority expectations for clinical pharmacology including formal meeting preparation and dossier authorship.
- Demonstrated experience supporting global regulatory submissions and participating in formal health authority interactions (FDA, EMA, PMDA, and/or other regulatory agencies).
- Proven ability to lead cross-functional teams and represent the function in strategic discussions and regulatory meetings.
- Proven ability to learn new information rapidly and effectively while working in a highly dynamic and fast-paced environment.
- Strong leadership, communication, and cross-functional collaboration skills.
- Excellent verbal and written communication with the ability to influence across the organization.
- Creative, innovative, strategic, problem-solving approach.
- Independent self-starter, but with an ability to be a strong team player in a highly collaborative environment.
Benefits
- Discretionary annual bonus
- Restricted stock units
Company overview
Rhythm Pharmaceuticals is a global, commercial-stage biopharmaceutical company headquartered in Boston, Massachusetts, founded in 2008. The company is dedicated to transforming the lives of patients with rare neuroendocrine diseases by developing and commercializing precision medicines that address the root causes of these conditions. Rhythm's primary focus is on melanocortin-4 receptor (MC4R) agonists, with its lead asset IMCIVREE (setmelanotide) designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. The company operates as a publicly traded entity (NASDAQ: RYTM) and has established commercial operations in North America, Europe, and other regions. Rhythm maintains a comprehensive clinical development program targeting rare genetic disorders of obesity and metabolic conditions, with additional investigational MC4R agonists and preclinical small molecules for congenital hyperinsulinism. The company has been recognized as one of The Boston Globe's Top Places to Work in Massachusetts for 2023 and 2024, reflecting its commitment to creating a collaborative and impactful work environment.